The announcement of the second premature and prescheduled sale of NanChip Molecular Biology Workstation to the genomic firm Egea BioSciences was an occasion for remembering how perfect, accurate, fast and predictive was NanoChip description offered by independent science observers and users to the kit, including Mayo Clinic. The NanoChip exceeded my former gold standards for accuracy, while providing the flexibility which encouraged me to acquire a NanoChip system immediately upon its commercial release. As a matter of fact, the man beat the schedule. The company's plan was to initiate sales in the third quarter of 2000. It seems that Dr Glen and others chose not to wait in line.
Good scientists hate to wait for breakthrough equipment.
Dr Evans confirmed prohost extremely positive opinion on the SNP kit and on Nanogen. Prohost is an independent publication providing information on biotech companies. Prohost does not accept compensation from companies that are featured or profiled. It is strongly recommended that any purchase or sale decisions to any of the featured companies be discussed with a financial advisor or broker prior to completing any such purchase or sale decision. All statements or expressions are the opinion of Prohost and are not meant to be a solicitation or recommendation to buy, sell, or hold securities.